Related Experiment Video
Updated: Aug 19, 2026
The Influence of Liver Resection on Intrahepatic Tumor Growth
Published on: April 9, 2016
Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary
Charlotte F J M Peeters1, Lioe-Fee de Geus, Johan R Westphal
1Department of Pathology 437, University Medical Center, PO Box 9101, Nijmegen 6500 HB, The Netherlands. c.peeters@pathol.umcn.nl
Abstract:
Removal of a primary colorectal tumor resulted in an increase in metabolic activity in its liver metastasis. Concomitantly, levels of angiostatin and endostatin in urine and plasma, respectively, dropped. This finding indicates that the primary tumor suppressed angiogenesis in its distant metastasis, and that removal of the primary lesion caused a flare-up in vessel neoformation and, thus, enhanced metabolic activity in its liver metastasis.
Insights
Removing a primary colorectal tumor increased liver metastasis activity. This suggests the primary tumor suppressed blood vessel growth (angiogenesis) in the metastasis, which resumed after tumor removal.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment
Background:
- Primary tumors can influence the growth and behavior of distant metastases.
- Angiogenesis, the formation of new blood vessels, is crucial for tumor growth and metastasis.
- Tumor-secreted factors can modulate angiogenesis in both primary and metastatic sites.
Observation:
- Following surgical removal of a primary colorectal tumor, a significant increase in metabolic activity was observed in its liver metastasis.
- Concurrently, levels of urinary angiostatin and plasma endostatin decreased.
- These changes suggest a dynamic interplay between the primary tumor and its metastatic lesions.
Findings:
- The primary colorectal tumor exerted an inhibitory effect on angiogenesis within its liver metastasis.
- Removal of the primary tumor led to a rapid resumption of vessel neoformation (angiogenesis) in the liver metastasis.
- This flare-up in angiogenesis correlated with enhanced metabolic activity in the metastatic site.
Implications:
- Primary tumor burden plays a critical role in regulating metastatic progression.
- Therapeutic strategies targeting the primary tumor may inadvertently promote metastatic activity.
- Understanding the primary-metastasis relationship is crucial for developing effective anti-cancer therapies.
